跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Triple-R
首页
药物
Triple-R
Triple-R
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of parthenolide derivatives as antileukemic and cytotoxic agents
US 2005272716 A1
申请人: CROOKS PETER A
优先权: 2005
US
8 件公开
MULTI-AGONIST AND USE THEREOF
EP 4353249 A1
申请人: THE UNITED BIO TECH HENGQIN CO LTD
优先权: 2021
CN
EP
US
WO
5 件公开
10,10-DIALKYL PROSTANOIC ACID DERIVATIVES AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE
US 2004157901 A1
申请人: ALLERGAN INC
优先权: 2003
CN
US
4 件公开
Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
US 7112674 B2
申请人: SENSIENT IMAGING TECHNOLOGIES
优先权: 2001
US
4 件公开
New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases
EP 1712557 A1
申请人: RWTH AACHEN
优先权: 2005
EP
US
3 件公开
Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
US 8552183 B2
申请人: WIESSLER MANFRED
优先权: 2006
EP
US
3 件公开
Pyrrolbenzodiazepines
US 7049311 B1
申请人: SPIROGEN LTD
优先权: 1998
US
3 件公开
Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US 10654809 B2
申请人: UNIV TENNESSEE RES FOUND
优先权: 2018
US
3 件公开
US 10314797 B2
申请人: UNIV TENNESSEE RES FOUND
优先权: 2016
CN
US
2 件公开
US 10806719 B2
申请人: UNIV TENNESSEE RES FOUND
优先权: 2018
US
US 11230523 B2
申请人: UNIV TENNESSEE RES FOUND
优先权: 2019
US
PYRAZOLE AMIDE BASED COMPOUNDS AND USES AGAINST BREAST CANCER THEREOF
US 2024376087 A1
申请人: COUNCIL OF SCIENT AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN
优先权: 2021
CN
US
2 件公开
GLP-1/GCG/GIP TRIPLE-RECEPTOR AGONIST AND USE THEREOF
EP 4596574 A1
申请人: SUNSHINE LAKE PHARMA CO LTD
优先权: 2022
EP
WO
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈